Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 4, 2006, Pages 529-532

  Ghaffari, Saeed Reza ^a,b,c,d   Sabokbar, Tayebeh ^a   Mollahajian, Hamid ^a   Dastan, Jila ^b   Ramezanzadeh, Fateme ^d   Ensani, Fereshteh ^a   Yarandi, Fariba ^e   Mousavi Jarrahi, Alireza ^a   Mohagheghi, Mohammad Ali ^f   Moradi, Abdolvahab ^g  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Cancer Research   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Imam Hospitals Complex   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cervical cancer in Iran; HPV infection in Iran; Human papillomavirus

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CHI SQUARE DISTRIBUTION; CLASSIFICATION; FEMALE; GENETICS; GENOTYPE; HUMAN; IRAN; ISOLATION AND PURIFICATION; NONPARAMETRIC TEST; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; UTERINE CERVIX; UTERINE CERVIX DISEASE; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

ADULT; CERVIX UTERI; CHI-SQUARE DISTRIBUTION; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; IRAN; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; STATISTICS, NONPARAMETRIC; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33947517894     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bernard HU, Chan SY, Manos MM et al. (1994). Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphism, nucleotide sequence, and phylogenic algorithms. JID, 170, 1077-85.
2. Chan PK, Lam CW, Cheung TH et al. (2002). Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst, 94, 1249-53.
3. Clifford GM, Smith JM, Aguado T, Franceschi S (2003). Comparison of HPV type distribution in high cervical lesions and cervical cancer: a meta analysis. Br J Cancer, 89,101-5.
4. Ho GY, Bierman R, Beardsley L, Chang JC, Burk RD (1998). Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med, 338, 423-8.
5. Husnjak K, Grce M, Magdic L,Kresimir P. (2000). Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical specimen's. Virological Methods, 88, 125-34.
6. Harro CD, Pang YY, Roden RB, et al. (2001). Safety and immunogenecity trial in adults volunteers of a human paillomavirus 16 L1 virus like particle vaccine. J Natl Cancer Inst, 93, 284-92
7. Im SS, Monk BJ (2002). New development in treatment of invasive cervical cancer. Obstet Gynecol Clin North Am, 29, 659-72.
8. Koutsky LA, Ault KA, Wheeler CM, et al. (2002). A controlled trial of a human paillomavirus type 16 vaccine. New Engl J Med, 347, 1654-51.
9. Lytween A, Sellors JW, Mahony JB (2000).Comparison of human papillomavirus DNA testing and repeat Papanicolauou test in women with low grade cervical abnormalities: a randomized trial. Can Med Assoc J, 163, 701-7.
10. Mortazavi SH, Zali MR, Raoufi M, et al. (2002). The prevalence of human papillomavirus in cervical cancer in Iran. Asian Pac J Cancer Prev, 3, 69-72.
11. Munoz N, Bosch FX, de Sanchose, et al. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl J Med, 384, 518-27.
12. Olsson SE (2006). Post infection prophylaxis of a quadrivalent HPV (types 6, 11, 16, 18) L1 virus like particle (VLP) Vaccine. Eur J Obst Gynecol Reprod Biol,(in press)
13. Parkin DM, Pisani P, Ferlay J (1990). Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 80, 827-41.
14. Parkin DM, Pisani P, Ferlay J (1993). Estimates of worldwide frequency of eighteen major cancers in 1985. Int J Cancer, 54, 594-606.
15. Rozendaal L, Walboomers JM, Van der Linden, et al. (2000). PCR based high risk HPV test in cervical cancer screenings gives objective assessment of women with cytomorphologically normal cervical smears. Int J Cancer, 68, 766-9.
16. Snijders P, Van den Brule A, van den Brule et al. (1990). the use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol, 71, 173-81.
17. Soler C, Allibert, P., Chardonnet Y, Cros P et al. (1991). Detection of human papillomavirus types 6, 11, 16 and 18 in mucosal and cutaneous lesions by
18. Van den Brule A, Class E, du Maine M et al. (1989). Use of anticontamination primers in the polymerase chain reaction for the detection of human papillomavirus genotypes in cervical scrapes and biopsies. J Med Virol, 29, 20-7.
19. Van den Brule A, Meijer C, Bakels V, et al. (1990). Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chainreaction. J Clin Microbiol, 28, 2739-43.
20. Walboomers JM, Jacob MV, Manos MM, et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
21. Yoshikawa H, Kawana T, Kitagawa K, et al. (1990). Amplification and typing of multiple cervical cancer-associated human papillomavirus DNAs using a single pair of primers. Int J Cancer, 45, 990-2.
22. Zur Hausen H (1991). Human papillomavirus in the pathogenesis of anogenital cancer. Virology, 184, 9-13